SEC Form 4 · accession 0001225208-17-018209
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Michael Fitzgerald
Officer — EVP & President, CRM
Period of report
Dec 1, 2017
Accepted (ET)
Dec 5, 2017 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 30, 2017 | G | 2,891 | $0.00 | D | 137,225 | D | |
| Common StockF2 | holding | — | — | — | 63,992 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $26.15 | Dec 1, 2017 | A | 306,372 | A | — | Dec 1, 2027 | Common Stock | 306,372 | 306,372 | D |
Explanation of responses
- F1Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F2Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
- F3Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on December 1, 2018, the first anniversary of the date of grant.